Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Sunderland · SciRah

Researcher profile · Semantic Scholar

K. Sunderland

Share profile

K. Sunderland — researcher profile on SciRah

h-index: 10
Works: 31
Citations: 1,017

Most-cited papers

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Matti Annala, G. Vandekerkhove, D. Khalaf, S. Taavitsainen +14 more
2018Cancer Discovery454 citations Open access
Semantic Scholar
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
D. Khalaf, Matti Annala, S. Taavitsainen, D. Finch +16 more
2019The Lancet Oncology312 citations Open access
Semantic Scholar
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
D. Khalaf, K. Sunderland, B. Eigl, C. Kollmannsberger +7 more
2019European Urology65 citations
Semantic Scholar
A randomized phase II cross-over study of abiraterone + prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC).
K. Chi, Matti Annala, K. Sunderland, D. Khalaf +8 more
201735 citations
Semantic Scholar
A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion.
S. Parimi, E. Tsang, A. Alexander, M. Mckenzie +6 more
2017Canadian Urological Association journal = Journal de l'Association des urologues du Canada23 citations Open access
Semantic Scholar
Phase 2 randomized cross-over trial of abiraterone + prednisone (ABI+P) vs enzalutamide (ENZ) for patients (pts) with metastatic castration resistant prostate cancer (mCPRC): Results for 2nd-line therapy.
D. Khalaf, Matti Annala, D. Finch, C. Oja +8 more
201822 citations
Semantic Scholar
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study.
M. Soleimani, K. Zou, K. Sunderland, W. Struss +9 more
2021European Journal of Cancer19 citations
Semantic Scholar
Effects of abiraterone (ABI) and enzalutamide (ENZA) on cognitive impairment and depressive symptoms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
S. Parimi, B. Eigl, K. Sunderland, M. Zulfiqar +7 more
201615 citations
Semantic Scholar
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
D. Khalaf, C. Avilés, A. Azad, K. Sunderland +8 more
2017Canadian Urological Association journal = Journal de l'Association des urologues du Canada14 citations Open access
Semantic Scholar
A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer.
C. Cho, K. Sunderland, T. Pickles, F. Bachand +2 more
2019Practical Radiation Oncology10 citations
Semantic Scholar
PACIFIC trial: A randomized phase II study of apatorsen and abiraterone in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) who have had PSA progression while receiving abiraterone (ABI).
K. Chi, M. Fleming, K. Sunderland, C. Albany +9 more
201710 citations
Semantic Scholar
Assessment of quality of life (QOL), cognitive function and depression in a randomized phase II study of abiraterone acetate (ABI) plus prednisone (P) vs enzalutamide (ENZA) for metastatic castrate-resistant prostate cancer (mCRPC).
D. Khalaf, K. Sunderland, B. Eigl, D. Finch +6 more
20179 citations
Semantic Scholar
Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer.
S. Parimi, S. Bondy, E. Tsang, M. Mckenzie +10 more
2018Canadian Urological Association journal = Journal de l'Association des urologues du Canada6 citations Open access
Semantic Scholar
Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy
Marie-Pier St-Laurent, George Acland, Sarah Nicole Hamilton, J. Hamm +7 more
2024Journal of Urology5 citations
Semantic Scholar
Small cell carcinoma of the bladder: A population-based analysis of long-term outcomes after radical cystectomy and bladder conservation with chemoradiotherapy.
Justin Oh, B. Eigl, P. Black, T. Pickles +3 more
2021Canadian Urological Association journal = Journal de l'Association des urologues du Canada4 citations Open access
Semantic Scholar
Treatment outcomes for metastatic castration-resistant prostate cancer (mCRPC) following progression on upfront androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPI) for metastatic castration-sensitive prostate cancer (mCSPC).
D. Khalaf, Liheng Chen, K. Sunderland, J. Vergidis +4 more
2022Journal of Clinical Oncology3 citations
Semantic Scholar
Real-world experience managing unresectable or metastatic small cell carcinoma of the prostate.
Jenny Ko, J. Adams, Tara McMillan, K. Sunderland +3 more
2022Canadian Urological Association journal = Journal de l'Association des urologues du Canada3 citations Open access
Semantic Scholar
Outcomes in patients (Pts) with advanced prostate cancer and inactivating germline mutations in BRCA2 or ATM.
S. Yip, D. Khalaf, W. Struss, K. Sunderland +5 more
20183 citations
Semantic Scholar
Presenting stage and risk group in men dying of prostate cancer.
S. Parimi, S. Bondy, M. Aparicio, K. Sunderland +5 more
2020Current Oncology2 citations Open access
Semantic Scholar
Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).
Jenny J. Ko, L. Mbuagbaw, S. Tyldesley, Jennifer Lowther +7 more
2024Canadian Urological Association journal = Journal de l'Association des urologues du Canada1 citations Open access
Semantic Scholar
Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).
S. Yip, K. Sunderland, Arshia Beigi, A. Angeles +7 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Main causes of death in aged horses in a retirement facility in California can be attributed to the digestive and musculoskeletal systems.
K. Sunderland, Verena K Affolter, Jennifer M Cassano, E. Berryhill +1 more
2026American Journal of Veterinary Research0 citations Open access
Semantic Scholar
Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).
Jenny J. Ko, L. Mbuagbaw, S. Tyldesley, Jennifer Lowther +7 more
2024Canadian Urological Association journal = Journal de l'Association des urologues du Canada0 citations
Semantic Scholar
Reply by Author.
Marie-Pier St-Laurent, George Acland, Sarah Nicole Hamilton, J. Hamm +7 more
2024Journal of Urology0 citations
Semantic Scholar
161: Organ Perforation and Clinical, Dosimetric, and Treatment Outcomes During Image Guided Cervix Brachytherapy
Alexa Dang, S. Zehnder, K. Sunderland, R. Urban +5 more
2022Radiotherapy and Oncology0 citations
Semantic Scholar
PO-1205: Small cell carcinoma of the bladder: Retrospective long-term outcomes of chemoradiation
J. Oh, B. Eigl, P. Black, K. Sunderland +1 more
2020Radiotherapy and Oncology0 citations
Semantic Scholar
Quality of life (QOL) for the treatment sequence of abiraterone acetate plus prednisone (AAP) followed by enzalutamide (ENZ) versus the opposite sequence for metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized clinical trial.
D. Khalaf, K. Sunderland, B. Eigl, D. Finch +6 more
20200 citations
Semantic Scholar
127 Small Cell Carcinoma of the Bladder: Retrospective Long Term Outcomes of Chemoradiation
Justin Oh, P. Black, B. Eigl, K. Sunderland +1 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations.
S. Yip, A. Angeles, Arshia Beigi, E. Warner +7 more
20180 citations
Semantic Scholar
EP-1359: Pain response in a Population-based study of Radium-223 for Metastatic Prostate Cancer
S. Tyldesley, S. Parimi, E. Tsang, F. Bachand +8 more
20170 citations Open access
Semantic Scholar
Predictors of failed same-day discharge in patients undergoing robot-assisted radical prostatectomy at a Canadian center
Michael Uy, Abdullah Alrumaih, Matthew R Fuda, R. Cassim +53 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Chi×20
Invite
K. Chi — researcher profile on SciRah
D. Khalaf×13
Invite
D. Khalaf — researcher profile on SciRah
D. Finch×11
Invite
D. Finch — researcher profile on SciRah
J. Vergidis×10
Invite
J. Vergidis — researcher profile on SciRah

×10

Invite

M. Zulfiqar — researcher profile on SciRah

S. Tyldesley×9

Invite

S. Tyldesley — researcher profile on SciRah

Invite

B. Eigl — researcher profile on SciRah

Invite

C. Oja — researcher profile on SciRah

Invite

M. Gleave — researcher profile on SciRah

Matti Annala×7

Invite

Matti Annala — researcher profile on SciRah

Invite

A. Wyatt — researcher profile on SciRah

G. Vandekerkhove×6

Invite

G. Vandekerkhove — researcher profile on SciRah